RENAL TRANSPLANTATION IN THE INBRED RAT : III. A STUDY OF HETEROLOGOUS ANTI-THYMOCYTE SERA by Guttmann, R. D. et al.
RENAL TRANSPLANTATION IN  THE  INBRED  RAT 
III.  A  STzrDY Or  HET~.ROLOOOUS ANII-THYMOCYI~ SF.~*, 
B~ R. D. GUTTMANN,§ M.D., C. B., CARPENTER, M.D., R. R. LINI~UIST,II  M.D., 
AND J. P. MERRILL~¶  M.D. 
(From the Departments of Medicine and Patttology, Peter Bent Brigham 
Hospital and Harvard Medical Sckod, Boston, Massachusetts 02115) 
Pr~z's 86 
(Received for publication  12 June 1967) 
The work of Woodruff and associates established that the administration of 
heterologous antisera prepared by immunization with lymphocytes will delay 
allograft rejection when used in a system of skin transplantation in the rat (1, 
2). Many subsequent reports in the recent literature have confirmed the im- 
munosuppressive potency of such antisera in skin graft and renal allotransplant 
systems, in some instances across major histocompatibility barriers (3-11). At 
present,  a  large  therapeutically successful series of patients exists having re- 
ceived renal  allotransplants with horse anti-human lymphocyte globulin ad- 
ministered as an adjunct therapy to the usual immunosuppressive methods (11). 
It is the purpose of this paper to report immunological studies of a  heterol- 
ogous antisera, made in rabbits to rat thymocytes, which have potent immuno- 
suppressive properties as tested in the relatively invariable system of renal allo- 
transplantation across a strong histocompatibility barrier in the inbred rat (12). 
Experimental data is presented that is relevant to an understanding of the dis- 
tribution and mechanism of action of anti-lymphocyte serum. Additional data 
is presented which indicates the conditions under which nephritis might be pro- 
duced by this reagent, since this complication may be the most limiting factor 
in its clinical application. 
Materials and Methods 
Animals.--All rats used were 250-350 g males  of the inbred Lewis, (Lewis  X BN)F1  hybrid 
(LBN F1), or  (Lewis X  F344)F1 hybrid  (LF344 F1)  strains (Microbiological Associates, 
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Inc., Walkersville, Md.). They were housed in individual cages at the time of study or after 
renal transplantation and fed Purina Lab Chow and water ad lib. Prior to collection of 18 hr 
urines for protein determinations,  they were deprived of food but not water, and  animals 
receiving iodinated proteins were maintained on water containing 0.05% KI and 0.45% NaC1 
(t3). 
Preparation of Antisera.--Five lots of pooled sera from two New Zealand white rabbits 
each were obtained after immunization with 109 twice washed thymocytes in Hanks' balanced 
salt solution. The cells were obtained by mechanical homogenization, sieved through eight 
layers of gauze, finally incorporated into 1 nil of complete Freund's adjuvant (Difco Labora- 
tories, Inc., Detroit, Mich.), and injected into the foot pads and multiple cervical sites.  10 
and  17 days later, booster injections of an equivalent number of thymocytes without adju- 
vant were given to the animals in the same regions. The rabbits were bled out by cardiac 
puncture 7-10 days after the last injection. The sera were heated to 56°C  for 45 rain and one 
lot was stored unabsorbed. Most batches of antisera were absorbed, however, two times with 
7.5%  by volume of washed rat  erythrocytes for 4  hr at 4°C and  afterwards with 10%  by 
volume of whole rat serum. 
Isolation of the Immunoglobulin G Fraction (AT IgG)i.--The IgG (7S, gamma G) fraction 
of the absorbed serum was obtained in the following way: One lot of whole serum was sub- 
jected to DEAE chromatography after dialysis and elution with 0.007 ~ Na phosphate buffer, 
pH  =  6.3  (14,  15). Since this eluate sometimes contained small amounts of hemoglobin or 
transferrin, it was further purified by chromatography on Sephadex G-100 in saline phosphate 
buffer, pH 7.1, or by rechromatography on DEAE cellulose,  Additional batches of absorbed 
rabbit  anti-rat  thymocyte serum were purified by precipitation at  18%  Na2SO4, dialyzed 
against 0.007 ~  sodium phosphate buffer, and eluted as described above. The resulting IgG 
was  immunochemically  pure  on  immtmoelectrophoretic  and  radioimmunoelectrophoretic 
analysis (16) when reacted against sheep anti-rabbit serum (Hyland Laboratories, Inc., Los 
Angeles,  Calif.). 
Preparation of the PepsSn Fragments.--The  absorbed and chromatographically purified IgG 
fraction of the rabbit anti-rat thymocyte serum was digested with pepsin to the 5S divalent 
fragment, F(ab')2, and the 3.5S univalent fragment, Fab', according to the method of Nisonoff 
et al. (17). After overnight dialysis at 4°C against 0.1 ~ Na acetate buffer, the pH was reduced 
to 4.5 and twice crystallized pepsin (Worthington Biochemical Corp., Freehold, N.J.) at pH 
4.5 was added at a  1:50 pepsin:globulin ratio. The mixture was incubated at 37°C for 8 hr 
and after precipitation at 18% Na~SO4 concentration, the precipitate was dissolved in distilled 
water and dialyzed exhaustively against buffered saline (0.14 M NaC1,  0.01 ~  sodium phos- 
phate buffer, pH 7.1) at 4°C. The univalent fragment, Fab', was obtained after dialysis of the 
F(ab% preparation overnight at 4°C against 0.1 M sodium acetate. The pH was lowered to 5.0 
and 2-mereaptoethanolamine HC1 was added to a final molarity of 0.12.  After flushing with 
nitrogen, this mixture was incubated at 37°C for 90 rain, dialyzed against 0.02 ~  iodoacet- 
amide in phosphate  buffered  saline for 8  hr,  then  exhaustively dialyzed against  repeated 
changes of phosphate-buffered saline, and finally sterilized through a Millipore filter. 
Assay of Antisera  and Fragments.--All  lots of crude or absorbed whole antisera, purified 
IgG fractions, or antibody fragments were evaluated for their ability to agglutinate rat thymo- 
cytes, and the lymphocytotoxicity titer was measured using a modification of the method of 
Gorer and  O'Gorman (18).  For agglutination, 0.025  ml rat thymocytes (5  X  106 cells/ml) 
t Abbreviations frequently used in this paper: Anti-thymocyte serum (ATS),  anti-thymo- 
cyte immunoglobulin G  (AT IgG), normal rabbit  serum  (NRS),  normal  rabbit  immuno- 
globulin G  (NR IgG). F(ab')~ and  Fab' refer to the bivalent and univalent antibody frag- 
ments  obtained  after pepsin  digestion,  recommended by  the committee on nomenclature, 
World Health Organization Bulletin, 1964. Anti-Lymphocyte serum (ALS) is referred to as 
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were added to 2-fold serial dilutions of antisera in lucite microtiter plates and incubated at 
room temperature for 90 rain. A drop of the cell suspension was placed on a  slide and was 
evaluated for agglutination under low power microscopy. Tnhibition of agglutination by the 
Fab' preparation was tested by treating 50 X  106 rat lymphocytes with AT Fab' (10 mg/ml) 
for 90 rain at room temperature, then by reacting these cells with serial dilutions of AT IgG. 
Lymphocytotoxic determinations were performed on samples similarly prepared for leukoag- 
glutination. However, after incubation of serial dilutions of antisera and cells at room tem- 
perature for 30 rain, 0.025  ml of a  1:10 dilution of freshly reconstituted lyophillzed normal 
rabbit serum (I-Iyland Laboratories) as a source of complement was added, and this mixture 
was incubated at 37°C for 90 rain.  Slide preparations were examined under phase-contrast 
microscopy and the number of viable and nonviable cells determined. In addition, various test 
antisera from rabbits, normal rabbit  sera, and globulins obtained from commercial sources 
were tested for their ability to agglutinate a  1% suspension of washed sterile sheep erythru- 
cytes after serial dilution in microtiter plates. The immune response in rats to sheep erythro- 
cytes was measured by hemagglutination 6 days after an intravenous injection of 0.5 ml of a 
10% suspension of washed sheep red cells. 
Otl~r Prepara~ions.--A  rabbit antiserum to rat glomeruli was prepared by immunization 
with glomeruli isolated in the following manner: Rat renal cortex was passed through a  100 
mesh sieve and washed 8-10 times after centrifugation at 1000 X  g until the suspension con- 
tained greater than 95% glomeruli (19). After incorporation into Freund's complete adjuvant, 
this  material  was injected into  the foot pads  and  cervical regions of New Zealand  white 
rabbits who were boosted 10 days later and bled 1 wk later. The serum was stored at --20°C 
until use. It was shown to have potent anti-kidney activity by its ability to produce an im- 
mediate protcinuria after intravenous injection. A more highly purified preparation  of glo- 
merular basement membrane was prepared from some of the isolated glomeruli by ultrasonic 
disruption (Raytheon model No. S102A) and differential centrifug~tion (19). 
Study of Animals wi~h Renal Transplants.--Ail  animals studied for modification of rejection 
were treated with the various antisera prior to renal allotransplantation. No injections of anti- 
thymus serum or the IgG or antibody fragment preparations were given to animals subsequent 
to the renal transplant. The allotransplants were carried out in Lewis recipients receiving LBN 
F1 hybrid kidneys and Lewis to Lewis isotransplants were done using a microvascular surgical 
technique (20).  The functional and immunopathologieal characteristics of this system of rat 
renal allotransplantation have been previously described  (12).  ImmunogeneticalIy, rejection 
reflects strong hlstoincompatibility (21) including disparity at the Ag-B locus (22) and is host 
vs. graft. By day 7, the renal transplant no longer functions and a specific glomerular, inter- 
stitial and tubular lesion is present. At this time as well, donor-specific hemaggiutinating and 
lymphocytotoxic isoantibodies are present in the serum of the recipient. The day 7 animal in 
this system was thus chosen as the functional and morphological control for the experimental 
animals described in this study. At the time of transplantation,  the recipient's right kidney 
was removed and, 4 days later, the left kidney was taken through a  small left flank incision. 
Effective renal plasma flow (ERPF) was measured on day 7 after allotransplantation  by a 
technique utilizing an analysis of the disappearance rate of 125I orthoiodohippurate (Hippuran, 
E. R. Squibb & Sons, New York, N.Y.) (23). Anesthetized animals are injected with 10-20/~e 
of t2sI-Hippuran, and radioactivity was monitored for 60 rain  over the head by a  collimated 
probe with a  1~  X  1}6 inches NaI crystal through  a  model 530A  Baird-Atomic gamma 
spectrometer  and  a  Texas Instruments  Rectiriter recorder.  ERPF is calculated using  the 
equation of Sapirstein based on a two compartment system for the plasma disappearance of 
the isotope: C •=  (Dblb2)/(Ab~ +  Bbl) (24). 
The sera of some animals receiving renal allotransplants were analyzed for the presence of 
donor-specific hemagglutinating antibody using the PVP method of Stimpfling (25) and donor 
specific lymphocytotoxic antibody (18). 
Tissue  Preparalion end Examination.--Thin  tissue slices  of kidney,  spleen,  and  thymus 1102  RENAL  TRANSPLANTATION IN RATS. HI 
from animals killed 7 days after transplantation were fixed in 2% cold glutaraldehyde, cold 
95% ethanol, and 10% formalin. After overnight fixation at 4°C in glutaraldehyde, the tissue 
was washed in 0.25 x¢ sucrose for a day or more (26), fixed secondarily in 1% osmium tetra- 
oxide, and, after dehydration in cold graded ethanol, embedded in Epon 812 (27) for prepara- 
tion of 1/~ sections that were stained with 1°-/o  tolnidine blue O in borax (28). Formalin-fixed 
tissue was embedded in paraffin, and 5 ]~ sections were prepared and stained with hematoxylin 
and eosin and Sehiff's leukofuchsin after periodic acid oxidation (PAS). For each transplanted 
animal, the transplanted kidney, the recipient's own kidneys, and the donor's nontransplanted 
kidney were available for microscopic study. The kidney, spleen, and thymus from control 
and experimental ~-ima]s were examined first without knowledge of the experimental groups, 
and finally all of the histopathologic material was reexamined with knowledge of the experi- 
mental  design.  Based  on previous experience with the sequential morphologlc alterations 
developing during renal allograft rejection with this rat  strain  combination,  the rejection 
process in the transplanted kidneys was quantitated by assigning a number corresponding to 
the posttransplant  day during which similar morphologic features would be expected in un- 
modified animals (12).  The immunosuppressive effect of anti-thymus sera was judged good, 
moderate, or poor if allografts removed 7 days after transplantation had the morphologic ap- 
pearance  of kidneys removed at 0-3  days,  4--5 days,  and  6-7  days after transplantation, 
respectively. Such grading is highly reproducible. 
Immunofluorescent examination of tissue and preparation  of immunoreagents were per- 
formed as previously described  (29)  using the fluorescent antibody technique (30)  on 95% 
cold ethanol-fixed, paraffan-embedded  tissue (31).  Fractions of rabbit or sheep antisera, ob- 
tained by DEAE-cellulose chromatography, to rat IgG (double chromatography on DEAE- 
cellulose),  ~lc globulin (32),  and  sheep antisera to rabbit IgG (Hyland Laboratories)  were 
conjugated with chromatographically purified fluorescein  isothiocyanate (FITC)  (Baltimore 
Biological Laboratories, Baltimore, Md.)  (33). Tissue sections were covered with labeled anti- 
serum, incubated for 30-40 rain, washed free of unbound  antisera,  and coverslips mounted 
with glycerin-saline.  Fluorescein-blocking controls were done by exposing tissue sections to 
unlabeled antisera prior to "staining" with labeled antisera and  absorbing  labeled antisera 
with purified antigen, in the case of the anti-IgG, prior to "staining". Ultraviolet light was 
supplied to a  Reichert microscope with fluorite dark-field objectives and condensers by an 
Osram HBO 200  watt mercury lamp and filtered with a  KG-2 exciter filter. Sections were 
viewed with a W2B barrier filter in place. 
StOics on Treated Ro~s.--White blood counts and total lymphocyte counts were done on 
blood obtained from the retroorbital plexus. ~m-globulin (C'3) levels were determined by a 
radial diffusion  immunoassay method  (34) using 7/zl samples of rat plasma inoculated into 
agar plates made with the rabbit antiserum to rat fllo-globulin described above. Urine protein 
excretion was measured by the method of Kingsbury (35), serum protein determinations were 
done by a biuret method (36), and double diffusion in agar gel was performed by the Ouchrer- 
lony method (37). Radioimmunoelectrophoresis of iodinated IgG fractions were performed by 
addition to whole rabbit serum and by development with a sheep anti-rabbit serum. Radio- 
autographs were developed after exposure to Polaroid 3000 film. 
Hemagglutinatlon oflgG-Coated Red Cdls.--Sheep erythrocytes coated with a subagglutinat- 
lag amount of rabbit IgG in the form of amboceptor (Baltimore Biological Labs)  were also 
employed as indicators of rat  anti-rabbit  IgG antibody.  Sheep red ceils plus amboceptor, 
1:8000-I: 16,000 dilution, were mixed and added in a  1% suspension into serial dilutions of 
test rat sera in microtiter plates. Mercaptan (DT.-penlcillamine) was added to dilutions of some 
sera to a final concentration of 0.1 ~r and incubated for 1 hr at 37°C before the red cells were 
added. Hemagglutination patterns were read after 4 and 18 hr (38, 39). 
IodinaHon of Proteins.--AT  IgG, normal rabbit IgG, (NR IgG), AT F(ab')~, and F  ab' 
fragments  were iodinated with lzsI according  to a  modification  (40)  of the chloramine-T GUTTMANN~ CARPENTER~  LINDQUIS%  AND  MERRILL  1103 
method of Greenwood et al. (41) at a protein concentration of 1 mg/ml, followed by exhaustive 
dialysis at  4°C  against  phosphate-buffered  saline,  pH  7.1.  The labeled proteins were used 
immediately, or after short periods of storage at 4°C, and centrifugation at 24,000  X  g for 30 
min was performed just prior to in vivo or in vitro use. For in vivo localization (42) or immune 
elimination studies (43), a volume of 0.4-0.5 ml containing 200-300 #g IgG was injected intra- 
venously with serial bleedings from the retroorbital plexus into heparinized capillary hemato- 
crit tubes and  20/zl of plasma  were pipetted  and  counted with a  Baird-Atomic No.  530A 
spectrometer. 
Tissue Localization of Labeled Proteins.--In normal LF344  F1 hybrid  and  Lewis rats,  a 
paired label technique (44) using 131I-labeled anti-thymocyte IgG and 125I normal rabbit IgG, 
or vice versa, was employed in all in vivo and in vitro experiments. The two reagents were 
mixed and centrifuged at 24,000  X  g for 30 min just prior to injection, and the animals were 
anesthetized with ether at various intervals thereafter. Prior to perfusion via the abdominal 
aorta with 6-10 blood volumes of 0.15 M NaCI, blood was obtained for counting so that the 
amount  of specific  antibody fixation could be determined  from comparison  of the  isotope 
ratiosinbloodandvarioustissuesaccordingtotheequation:  131I-fixed  =  131Iorzan  --  [(181Iplasma  / 
125Iolasma) 125Ioraan].~ The results were expressed as percentage of injected antibody or as specific 
activity. Some kidneys were fractionated into glomerular and nonglomerular fractions prior 
to counting (19) and selected kidneys were homogenized in a  Sorvall omnimixer followed by 
precipitation with 20% trichloroacetic acid (TCA) and  the amount  of protein-bound radio- 
activity determined. Some of the homogenates were subjected to exhaustive dialysis against 
water to determine the per cent of dialyzable (free or peptide-bound) radioactivity. A few of 
the dialysates were concentrated by lyophilization and  chromatographed  on a  Bio-Gel P-2 
column (45) to determine the relative amounts of 181I and 125I bound to the peptide fraction. 
Radioautography of kidneys after formalin fixation and paraffin-imbedding was performed on 
5/~ sections using Kodak NTB-3 nuclear track emulsion (46). For these experiments, 125I AT 
IgG or 125I NR IgG of the same specific activity were given to pairs of animals and the kid- 
neys removed 10 min and 4 days later after perfusion. The paired label technique was also 
used to determine in vitro binding to purified glomerular basement membrane suspended in 
10% bovine serum albumin in siliconized  glassware.  After incubation at 37°C with constant 
agitation, the sediment was washed once prior to counting. 
RESULTS 
In  Vitro Characteristics  of the tteterologous  A ntisera and Suppression of Re- 
sponse  to Sheep Erythrocytes.--The titers of the rabbit  anti-rat  thymocyte sera 
using  the  lymphoagglutination  technique  were  from  1:384  to  1:786  with 
lymphocytotoxic  titers  in  the  same  range.  There  was  a  1-2  tube  reduction  in 
titer  after  purification  of  the  antibody  by  DEAE-cellulose  chromatography. 
The agglutination  titer of the  F(ab')2 preparation  was  1 : 192  at  a  protein  con- 
centration  of  10  mg/ml,  and  it  had  no  cytotoxic  titer.  The  anti-glomerular 
serum  had  no lymphoagglutination  titer but  was  cytotoxic at  1:16.  The  Fab' 
preparation  inhibited  agglutination  by  AT  IgG  at  a  dilution  of  1:64.  The 
F(ab')2  and  Fab'  (1%)  preparations  showed  s20 values of 5.7  and  3.4,  respec- 
tively, by analysis in a  Spinco model E  ultracentrifuge 3 (Text-fig. 1). 
2 1251 and 13II were counted with a 3 inch thallium-activated NaI crystal by a  Baird-Atomic 
model 540 gamma spectrometer with appropriate corrections for their gamma spectra.  Sam- 
ples did not exceed  a 2 )<  104 cpm rate. 
3 Kindly performed by  Dr.  T.  J.  Gill, III,  Department  of Pathology,  Harvard  Medical 
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By immunoelectrophoresis,  the crude unabsorbed  sera sometimes  contained 
antibody to serum proteins,  mainly ct- and ~3-globulins,  but these were not de- 
tected after absorption with rat serum. Also, anti-rat  RBC antibody was dem- 
onstrated by hemagglutination in several of the preparations  in titer of 1 : 16 to 
TExT-FIG. 1.  Ultracentrifuge patterns of the pepsin-digested anti-thymus  lgG (5.7S) and 
its reduced and alkylated fragment (3.4S). Both patterns shown are at 48 rain at 48,000 rpm 
in a Spinco model E ultracentrifuge. Temperature  is 20°C with 55  ° angle for the 5.7S and 65  ° 
angle for the 3.4S fragments. 
1:64, and  this was easily removed by absorption.  All of the absorbed  sera,  as 
well as all but one of the IgG fractions and two of three  normal rabbit  serum 
preparations,  contained agglutinins in low titer to sheep erythrocytes (Table I). 
Mercaptan  treatment  produced  no  decline  in  anti-sheep  cell  titer  of  the  AT 
globulins,  fraction  (lot No. 6),  indicating that  the bulk  of antibody was prob- G~NN,  CARPENTER,  LINDQUIST,  AND  MERRILL  1105 
ably 7S. The anti-thymocyte agglutinating titer of this fraction was 1:256 and 
this specificity was not significantly affected by absorption with sheep red cells, 
although the latter reduced the anti-sheep red blood cell titer from 1:8 to less 
than 1:2 and had a profound effect on the antibody response to sheep erythro- 
cytes. Whereas untreated rats, or rats pretreated with 10 mg normal rabbit IgG 
(NR IgG)  containing no anti-sheep antibody, developed a  hemagglutinating 
titer of 1: 384, rats pretreated with 10 mg AT globulins (lot No. 6) over a 5 day 
period had titers of only 1:12 to  1:24. However, with absorption of the AT 
globulins (lot No. 6) as noted above, abolition of the immunodepressive effect 
TABLE I 
Antibody Activity in Various Rabbit Reagents ~Ath Sheep Erythrocytes 
Preparation (lot No.)*  Agglutination  titer 
NRS (Hyland Labs., Los Angeles, Calif., No. 3042C1) 
NR globulins (Mann Research Labs., New York, N.Y. No. 
S1869) 
NR globulins (Pentex Inc., Kankakee, Ill. No. 51) 
AT IgG (2) 
AT IgG (3) 
AT serum (4) 
AT IgG (4) 
AT IgG (5) 
AT globulin (6) 
Anti-glomemli serum 
1:8 
1:4 
Negative 
1:4 
Negative 
1:32 
1:4 
1:4 
1:8 
1:8 
* The protein concentration of the globulin fractions is 10 mg/ml. 
on the response to sheep erythrocytes was observed. These results suggest that 
the passively transferred anti-sheep cell antibody (probably 7S) plays a role in 
suppressing  the  response  to  subsequently  administered  sheep  erythrocytes, 
rather than the anti-lymphocyte effects of the antisera. 
In Vivo Effects.--There was a profound lymphopenia with a 79 4- 12 % (SD) 
decrease of peripheral lymphocytes and slight decrease of 25 4-  11.5 %  (SD) in 
serum/3it-globulin 4 hr after a single intravenous injection of 1.2 mg of AT IgG. 
There was a decrease of 53 4-  10 %  (SD) in the peripheral lymphocyte count 4 
hr after the intravenous injection of 1.2 mg of AT (Fab')~ and a 26 4- 4% (SD) 
decrease after the injection of 1.2 mg AT Fab' fragment. Injection of 1.2 mg of 
NR IgG caused a decrease of 14 4- 5 % (SD) in peripheral lymphocyte count. The 
net changes of/3it-globulin level in these latter three  groups were --7 4-  7 %, 
--8 4- 7%, and +11 4- 5%, respectively. 
Activity against Mast Cells.rain an in vitro cytotoxic assay for anti-mast cell 
activity/it was demonstrated that the absorbed ATS caused a marked release 
4 Kindly performed by Doctors M. Valentine, R. Orange, and K. F. Austen, Robert Breck 
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of histamine  and hence either contained antibody to mast cells present in the 
thymus preparations or represents cross-reacting antibody. 
The Immunosuppressive Effect of Anti-Thymu3 Serum.--To  test the immuno- 
suppressive  effectiveness  of  all  the  preparations,  animals  were  grouped  into 
those that received the whole unabsorbed, crude ATS by intravenous injection, 
those that received the purified AT IgG fraction at two dosage levels, and those 
that received AT F(ab')~, AT Feb', NR IgG, NR  F(ab'),, and rabbit anti-rat 
TABLE II 
Effect of Pretreatment on Renal Allografl Rejection* 
Rat No.  Pretreatment dose  Effective renal plasma flow  Morphologlc evidence  of immunosuppression 
1-02 
1-82, 1-83 
2-13, 2-15, 2-17, 2-19 
2-48, 4-01, 4-02, 
4-03, 4-09, 4-11 
2-05, 2-06, 2-07 
4.0 ml AT serum 
0.7 ml AT serum 
6 mg AT IgG 
10 mg AT IgG 
6 mg NR IgG 
rnl/mi,llO0 g$ 
1.05 
0.99, 0.95 
0.10, 0.32, 0.75, 
1.30 
0.78, 1.08, 0.60, 
0.67,  1.06,  1.18 
0.08, 0.06, 0.04 
Good 
Good 
Poor--good 
Good 
Poor (completely re- 
2-93, 2-94, 2-95 
3-21, 3-24 
3-67, 3-68 
3-56, 3-79, 3-86 
3-62, 3-63 
6 mg AT F(ab')2 
23-30 mg AT F(ab')~ 
23-30 mg NR F(ab')2 
23-30 mg AT Feb' 
3.0 ml anti-glomeruli 
serum 
0.13, 0.09, 0.21 
0.63, 0.74 
0.07, 0.08 
0.63, 0.30, 0.66 
0.08, 0.11 
jected) 
Poor 
Moderate--good 
Poor (completely re- 
jected) 
Moderate--good 
Poor (completely re- 
jected) 
* Day 7 animals studied for effective renal plasma flow and killed for histology. 
~; Based on the clearance of ~5I orthoiodohippurate.  See text for description of method. 
Unilaterally  nephrectomized rats have ERPF --- 0.91 4- 0.23 (SD) and anephric rats have 
ERPF =  0.06 4- 0.03 (SD) measured by this method. 
glomeruli serum (Table II). Allotransplanted kidneys removed 7 days after trans- 
plantation from control animals treated with NR IgG, NR F(ab ~) 2, or anti-glo- 
meruli  serum  show  the  typical  morphologic features seen in untreated  7 day 
renal allografts (Fig.  1). Numerous mononuclear cells  with large vesicular nu- 
clei  and  one or  more prominent  nucleoli  diffusely infiltrated  the  cortical  in- 
terstitial  tissue  and  surrounded  individual  cortical  tubules  and  glomeruli. 
Tubular necrosis was widespread in the cortex.  Glomerular capillary loops were 
bloodless and occluded with fibrillar,  PAS-positive  material.  Prominent  large 
glomerular  epithelial  cells  contrasted  with  decreased  numbers  of  endothe- 
lial  and mesangial  cells  which  were  frequently  pyknotic  and  karyorrhexic. 
These  animals had ERPF values in the range obtained in anephric rats. GUTTMANlg~  CARPENTER~ LINDQUIST,  AND  MERRILL  1107 
Transplanted  kindeys removed 7  days after  transplantation  from animals 
receiving unabosrbed ATS or 10 mg of AT IgG showed morphologic evidence 
of good immunosuppression.  Infiltrating mononuclear cells  were  confined to 
perivascular areas. Tubules and glomeruli showed no evidence of rejection or 
TABLE III 
Donor Pretreatment zoigh Anti-Thymocyte Antibody: Transfer of the lmmunosuppressive Effect 
with Kidney-Bound Antibody 
Rst No. 
2-71 
2-72 
2-78 
2-79 
2-84 
2-96 
2-97 
3-25 
3-26 
3-27 
3  -29 
3-30 
Pretreatment dose 
6-15 mg AT IgG (4) 
16 mg NR IgG 
25 mg AT IgG (5) § 
25 mg AT IgG  (5) 
Absorbed with Lewis thymocytes 
Effective renal 
plasma flow* 
ral/rain/lO0 g* 
0.33 
0.32 
0.23 
0.33 
0.06 
0.11 
0.15 
0.17 
0.22 
0.29 
Recipient  titer to 
NR ~O~ 
Whole fiter [ Mercaptan-  resistant  I 
1:96 
1:24 
1:24 
1:12 
1:6 
0.05 
0.04 
Not done 
Not done 
0 
0 
1:6 
* Renal function 7 days after allotransplantation. 
Hemagglutinin titer of sheep erythrocytes coated with NR IgG reacted with the serum 
of the recipient receiving the donor-pretrcated kidney 7 days after allotransplantation. 
§ This lot of antisera was prepared by immunizing rabbits with LBNF1 thymocytes. Ab- 
sorption with Lewis thymocytes was incomplete and  reduced the  lymphoagglufinin and 
lymphocytotoxic  fiter g-fold. Theoretically, any antibody directed against LBNF1  transplant 
antigens should still be present after absorption. 
ischemia (Fig. 2). These rats had day 7 ERPF values in the normal range for 
rats with one kidney, while the rats pretreated with 6 mg of AT IgG showed 
poor to good immunosuppression with variable function correlating well  with 
the histology. All pretreated animals had normal peripheral blood lymphocyte 
counts 7 days after transplantation.  Day 7 sera from rats  treated with anti- 
thymocyte serum did not have donor-specific isoantibody by the hemagglutina- 
tion  and  lymphocytotoxic tests.  These  antibodies  are  usually found  at  this 
time  in the sera of recipients with completely rejected kidneys. Moderate to 1108  RENAL  TRANSPLANTATION  IN  RATS, 
good suppression of renal allograft rejection was seen in animals  treated with 
the AT F(ab')2 and AT Fab', with renal function from near normal to normal. 
Severe nephritis developed in the host kidney of all animals  pretreated with 
unabsorbed ATS.  Most  glomeruli,  but not all,  showed hypercellularity  and 
mesangial matrix  increase  which not infrequently involved only a  portion of 
the  glomerular  tuft.  Endothelial,  mesangial,  and  epithelial  cells participated 
in  the  glomerular  hypercellularity.  Occasional  adhesions  between  capillary 
loops and Bowman's capsule occurred and proliferation of capsular epithelium 
formed occasional  "crescents." The kidneys of recipient animals  treated with 
NR IgG and AT IgG and removed at the time of allotransplantation  showed 
slight evidence of nephritis characterized by mild focal hypercellularity. 
Large and medium-sized thymocytes were depleted from the thymic cortex 
of most animals receiving ATS (Fig. 4), but the majority of the thymuses from 
AT  IgG or  antibody fragment-treated  rats  did not  show consistent  altera- 
tions and, when examined "blind" without knowledge of the experiment, they 
could not be consistently separated from control  animal  thymuses  (Fig.  3). 
Similarly,  only  some  spleens  showed  small  follicles  with  large  lymphocyte 
depletion. 
The Immune Response  to the Foreign Protein.--After an intravenous course 
of five daily injections of 1.2 mg of AT IgG, agar gel diffusion analysis showed 
circulating  foreign protein  in  the  recipient  animals  at  day  7 after  the  first 
injection, but by day 14 this was no longer measurable. At day 14 and day 21 
when foreign protein was not circulating,  there was no precipitating antibody 
to the rabbit protein, even though there was a very high titer of hemagglutinat- 
ing  antibodies  and  a  very rapid  immune elimination  of the foreign protein. 
Table IV shows that all groups of rats which received AT IgG, the antibody 
fragments,  or NR IgG had  immune  elimination  of 12~I-labeled NR IgG  ad- 
ministered intravenously 2 wk after their first injection,  which in these cases 
corresponded to the first day of the allotransplant.  It is noteworthy that the 
animals  treated with the AT antibody showed a more rapid immune elimina- 
tion  of the foreign protein  than  their  respective NR IgG injected controls. 
Control uninjected rats showed no evidence of immune elimination  of this test 
dose of 125I NR IgG during  a 3 wk period, and the plasma radioactivity de- 
clined as a single exponential with a half-life  (ta/~) of 6.5 days. tIemagglutina- 
tion titers obtained using rabbit IgG-coated sheep RBC's correlated well with 
the immune elimination  results. Animals  receiving  the anti-thymus  antibody 
or antibody fragment had a significantly  higher titer than animals receiving the 
NR IgG or NR F(ab')2. Thus,  the immune  response  to the foreign protein 
under the "immunosuppressive" influence  of AT IgG was increased.  Most of 
the antibody was mercaptan-sensitive, i.e.,  19S. A single large dose of the AT 
IgG or a series of five subcutaneous injections resulted in titers as high as five 
small intravenous doses. 
Immunofluorescent  Tracing.--AT IgG conjugated to FITC was used in both GUTTMANN~ CARPENTER~  LINDQUIST~ AND  MERRILL  1109 
TABLE IV 
Antibody Respo~e to Rabbit IgG 
Rat No. 
2-01 
2-02 
2-03 
2-08 
2-09 
2-10 
2-11 
2  -20 
2-21 
2-22 
2-23 
2  -68 
2-81 
2-69 
2-70 
2-40 
2-41 
3-39 
3-57 
3-58 
2-73 
2  -74 
3-19 
3-20 
3-56 
3-79 
3-62 
3-63 
Pretreatment dosage 
6 mg NR IgG 
None 
6 nag AT IgG 
6 mg AT IgG (single injection) 
6 nag AT IgG (s.c.) § 
6 mg AT F(ab')2 
6 mg NR F(ab')2 
23-30 mg AT Fab' 
3.0 ml anti-glomeruli serum 
Immune 
elimination* 
++ 
+ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
~tion fiter~ 
1:384 
1:768 
1:384 
1:384 
1:192 
1:3 
0 
1:384 
1:192 
1:24 
1:96 
Mercaptan- 
resistant 
1:24 
1:48 
1:96 
1:96 
1:48 
1:96 
1:96 
0 
0 
48 
24 
0 
0 
* Immune elimination of 200-300 #g 125I NR IgG 14-16 days after the first in: ection and 
7 days after the last injection. Scored according to the time of >99% disappearance of plasma 
radioactivity. -- Negative; +  4 days; ++  i  day; +++  10 rain. 
Sheep  erythrocytes coated  with  1:8000-1:16,000  dilution  of amboeeptor  and  titered 
using serum obtained from rats 14 days after their first injection. 
§ Subcutaneous injection in the cervical region. All other injections were by the intravenous 
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in vivo and in vitro tracing experiments. 5 mg of the conjugate were injected 
into rats, and 21/~ hr later the animals were killed, and the spleen,  thymus, 
lymph nodes, lung, heart, and kidneys obtained for immunofluorescent study. 
No localization was found in this way at this dosage level. To gain more sensi- 
tivity, sections of normal spleen, thymus, lungs, heart, lymph node, liver, and 
kidney, which were stained in vitro with FITC-AT IgG, showed cytoplasmic 
localization of the fluorescent antibody in cells of the spleen and thymus with 
no preferential distribution. Direct staining of the other organs was  negative. 
21/~ hr after a single injection of 0.5 ml of the crude unabsorbed ATS, the kidney 
contained a  considerable amount of rabbit  IgG, rat IgG, and rat/3~-globulin 
TABLE  V 
Anti-Thymocyte Organ Localization after a Single Intravenous  Injection in Normal 
Rats of 13xi AT IgG (4)/t251 NR [gG  As a Paired Label* 
No. Rat 
2-89 
2-90 
2-54 
2-53 
2-91 
3-11 
2-92 
3-12 
Time 
10 rain 
10 min 
2.5 hr 
4th day 
4th day 
4th day 
7th day 
4th day~ 
Kidney 
% 
1.30 
0.92 
0.57 
0.33 
0.12 
0.16 
0.06 
0.04 
Liver 
% 
2.00 
1.92 
2.74 
<0.01 
<0.01 
0.12 
<0.01 
0.04 
Spleen 
% 
0.19 
0.21 
0.78 
0.04 
<0.01 
0.02 
0.01 
<0.01 
Lung 
% 
0.31 
0.25 
0.69 
0.13 
0.07 
0.04 
<0.01 
0.02 
Thymus 
% 
0.01 
0.02 
0.02 
<0.01 
<0.01 
0.02 
<0.01 
<0.01 
Lymph 
node 
% 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
Heart 
% 
0.03 
0.07 
<0.01 
<0.01 
<0.01 
<0.01 
Muscle 
% 
<0.01 
<0.01 
<0.01 
0.01 
Skin 
% 
q 
q 
<0.01 
<0.01 
<0.01 
<0.01 
131  181  12B  126  * Expressed as per cent fixed of injected laiI =  Ior~an -- [(  Iplasma/  Ivlasma)  Iorgan]. 
$ Injected with paired label subcutaneously  in cervical region. 
deposited in granules in the mesangium and along capillary walls of glomeruli, 
suggesting the presence of immune complexes by in vitro tracing. 
Paired Labd Antibody Organ Localization of  Anti-Thymus IgG.--Table 
V presents the data obtained in one of the experiments in which localization in 
various organs of the AT IgG was determined using the paired label technique. 
131I AT IgG and 12sI NR IgG were  injected into groups of rats which were 
killed 10 rain, 2.5 hr, 4 days, and 7 days later. As can be seen, there was a sig- 
nificant amount of AT IgG radioactivity in the kidney at various times after 
intravenous  injection  of  the  paired  label.  The  amount  of  radioactivity in 
spleen, lung, and liver was significantly greater at 10 rain and 2.5 hr than at 
4 days, and  probably  reflects the  early deposition of  immune complexes  or 
denatured protein. In a saturation experiment where 200 #g of the AT IgG/NR 
IgG-paired  iodine label were  injected with increasing amounts of unlabeled 
AT IgG, there was progressive increase of fixation in kidney, lung, and spleen 
measured 4 days later, as shown in Text-fig. 2.  Saturation of kidney did not 
occur at a level of 80/zg, contained in 15 mg AT IgG, the maximum amount GUTTM.A1VI~, CARPENTER, LINDQUIST, AND MERRILL  1111 
that  could be administered without  toxic  effects to  the  animals.  Since  Katz 
et al (47) found that rabbit anti-rat spleen antibody saturated kidney at a level 
of 220/~g, the lack of a plateau with anti-thymus antibody at this level is not 
surprising.  Although  the  thymus seemed  to be saturated  at  the 5  mg level, 
Text-fig. 3 shows that because of the decreasing weight of thymus and increas- 
80 
x 
x  Kidney  / 
'~ Lung  o  Spleen  •  Thymus 
60 
'~  x  x 
40 
20 
o 
0  5  I0  15 
AT _TgG (rag/ 
Tzx~-Fzo.  2.  Organ localization of anti-thymus  IgG: Saturation  experiment in  which 
increasing amounts of unlabeled AT IgG were given as a single intravenous dose with a fixed 
dose (300/zg) of paired label 126I AT IgG/181I NR  IgG to normal rats and specific radio- 
activity determined 4 days later. Assuming identical distribution of labeled and unlabeled AT 
IgG, the absolute amount in/~g fixed per organ was calculated and the relationships are shown 
above. Since doses  of AT IgG greater than 15 mg were usually quite toxic, complete saturation 
of kidney was not possible. 
ing weight of spleen, saturation may actually occur per unit weight at a slightly 
higher dose for thymus and lower dose for spleen. A second lot of AT IgG gave 
qualitatively similar values for all  organs,  with  1.14%  in kidneys  at  2.5  hr 
and 0.66% at 4 days, while liver contained 2.74% and <0.01%, respectively. 
From the ratio of the two isotopes in plasma 10 rain after injection, it could 
be calculated that between 20.2 and 33.6 % of the radioactivity of AT IgG was 
cleared from plasma, suggesting a high percentage of anti-rat tissue antibodies. 
However,  since  the  sums  of the  localization values for the  organs measured 
(Table V) were less than 4 %, 20-30 %  of the injected AT IgG must have been 
diffusely  distributed  elsewhere,  either  as  anti-rat  IgG,  or  because  the  AT 1112  RENAL  TRANSPLANTATION  IN  RATS.  HI 
IgG was partially denatured. Since two lots of AT IgG and NR IgG used in 
separate  experiments  with  the  iodine  labels  reversed  gave  similar  results, 
and since injection of the paired label into a  rabbit produced no significant 
difference in the plasma ratio at  10 rain,  denaturation of the antibody IgG 
seemed  unlikely.  Nevertheless,  an  increased  susceptibility  of  immune  IgG 
to denaturation during labeling is still a  possible explanation, and could also 
explain the greater degree of renal tubular localization shown below. The serum 
k 
I000 
750 
500 
250 
Spleen 
Thymus 
0  I  I  I 
5  I0  15  30 
AT.r.gG (mg/ 
TsxT-Fm. 3.  Alterations in weights of spleen and thymus with increasing doses of AT IgG; 
same rats as in Text-fig. 2. 
clearance of the 12sI AT F(ab')2 and z~5I Fab' showed a multiexponential dis- 
appearance curve with an approximated half-life of less than 0.5 days. Within 
the first 24 hr, 47 % of the injected AT F(ab')~ radioactivity was recoverable 
in the urine, showing the rapid renal clearance and catabolism of this frag- 
ment. 
Table VI presents the localization data in the kidney when 125I AT IgG and 
mI NR  IgG was  used as  a  paired label  and  the  kidneys fractionated into 
glomernlar, tubular, and medullary fractions. With the exception of the ani- 
mal injected subcutaneously, there was  a  constant amount of radioactivity 
(10%) in the glomerular fraction of rats killed at various times after injection. 
Although the major proportion of total radioactivity was not in the glomer- 
ular fraction, on a  weight basis the glomeruli had 19.6 times the specific  ac- GUTTMANN,  CARPENTER,  LINDQUIST,  AND  MERRILL  1113 
tivity  of  the  tubular  fraction.  Radioautography dearly  demonstrated  the 
specific glomerular localization  of AT IgG compared to the low background of 
radioactivity from NR IgG injected controls.  (Figs. 5 and 6). 
Text-fig. 4 shows the half-disappearance time of the radioactivity from the 
TABLE  VI 
Anti-Thymocyte Localization  in Kidney 
Rat No.  Time  Medullary  Tubular  Glomerular 
2-89 
2-90 
2-91 
3-74 
2-92 
3-78" 
10 min 
10  " 
4 days 
4  " 
7  " 
4  " 
% 
6.9 
19.3 
11.3 
5.0 
5.0 
16.0 
% 
82.1 
71.6 
74.8 
87.0 
82.4 
84.0 
% 
11.0 
9.1 
13.9 
8.0 
12.6 
<0.3 
Per cent distribution of specific antibody radioactivity using paired label technique. 
* Isotope injected subcutaneously in the cervical region. All other injections of  200 #g 
of the paired label were given intravenously. 
1.00 
0.80 
0.60 
0.40 
¢> 
0.20 
0.10 
0.08 
0.06 
0.04 
0.02 
•  f~  =2.1Doy$ 
! ~ =2.6 0o¥$ 
o.ot  I  I  I  I  I 
2  4  6  8  10 
TIME ('DAYS) 
Whole Kidney 
TCA-Precipifoble 
TzxT-FIo. 4.  Localization of anti-thymus IgG  in  kidney at intervals after a  single intra- 
venous injection of  the paired iodine labels. The whole kidney values are shown as the mean 
and range obtained from two to four  animals.  The amounts of radioactivity which are precipi- 
table with TCA are proportional to the total amount and show a  similar half-time disappear- 
ance rate. 1114  RENAL  TRANSPLANTATION  IN  RATS.  III 
kidney on the basis of the organ localization data. It is seen that a portion of 
the AT  IgG radioactivity disappeared  from the  kidney in  the first 4  days 
very rapidly with a half-disappearance time of 2.5 days, while there was very 
little change in radioactivity between the 4th  and  7th  days, suggesting the 
presence of a population of antibody fixed in kidney (Text-fig. 5). In another 
1.0 
Z2 Days 
.~  ~=14 Days 
I~  ~  Days 
0.01 
•  Tubular 
o  GBomerular 
o.ool  I  I  I  I  I 
I  .3  5  T  9 
TIME  (C~YS] 
TExT-FIG.  5.  Localization of anti-thymus IgG in kidney: comparison of tubular and glo- 
merular fractions at intervals after a single intravenous injection of the paired iodine labels. 
The disappearance rates in this experiment are the same for the two fractions. 
experiment, the disappearance rate of radioactivity leaving an isotransplanted 
kidney from a  donor injected with  the  paired  label  and  the  disappearance 
rate of the paired label from an injected recipient grafted with a  "cold" iso- 
transplanted kidney showed a  half-disappearance time of 0.8  and  1.1  days, 
respectively.  The  nature  of  tubular  radioactivity was  demonstrated  when 
radioautographs 10 min and 4 days after injection of 125I AT IgG or 1~5 I  NR 
IgG  revealed  predominantly  proximal  tubular  cytoplasmic  localization, 
present in the NR IgG-injected controls, but in greater concentration in the 
antibody-injected animals. At 4 days, the grains appeared to coalesce, consistent GIYrTMANN, CARPENTER, LINDQUIST, AND M~ERRILL  1115 
with the concept that such tubular localization  represents a catabolic site for 
the reabsorbed and perhaps altered IgG reacting at distant sites. There was no 
apparent  localization  along  blood vessels or  tubular  basement  membranes. 
Chromatography  of dialyzed kidney homogenates of both NR IgG and  AT 
IgG--injected  rats  on  Bio-Gel  P-2,  revealed  the  presence  of  peptide-bound 
radioactivity in both instances. 
Since the kidney is an organ of excretion for iodide and small peptides, locali- 
zation of radioiodide per se is not proof of antibody fixation.  Data on TCA- 
precipitable (proteins and large polypeptides) radioactivity (Fig. 4) gave simi- 
lar  kinetics  when  compared  to  the  whole  kidney  radioactivity,  and  since 
49-61% of total radioactivity was TCA-precipitable and a similar percentage 
was nondialyzable in these experiments, the contained radioactivity in kidney 
was at least partly bound to protein and, hence, must have been due to specific 
antibody.  In  another  experiment,  the  renal  pedicle  of  a  rat  was  clamped 
prior to and I hr after the injection of the paired label. 4 days later, the clamped 
kidney contained  about one-third  the  amount  of TCA-precipitable  radioac- 
tivity as did the undamped kidney, probably reflecting  the acquisition of dis- 
sociating antibody. 
The Effect  of Donor Pretreatment on the 7  Day  Allotrransplant.--When  it 
became apparent that there was a significant  amount of renal binding by anti- 
body, it seemed possible that a locus of action could be on the kidney (target 
organ) itself. To test this hypothesis, one group of LBN Fa hybrid donors was 
pretreated with a  course of 6-15 mg of lot No. 4 of AT IgG over a  5-9 day 
period,  and  kidneys  were  transplanted  into  unmodified  Lewis  recipients. 
Another group of donors were pretreated with 16 mg of NR IgG  and  subse- 
quently transplanted.  A subsequent group of LBN F1 donors were pretreated 
with  25 mg of lot  No. 5  of AT IgG,  obtained by immunizing  rabbits with 
LBN F1 thymocytes, and then transplanted while  a control group was given 
an equivalent amount of AT IgG (lot  No. 5), which was absorbed with  10' 
Lewis thymocytes for 4 hr at 4°C, resulting in a 4-fold decrease in titer. These 
two latter groups were done to rule out the possibility that antibody to genet- 
ically specific histocompatibility antigens was being made by the rabbits, and 
that the donor pretreatment phenomenon would be a form of "heterologous" 
enhancement. 
Donor pretreatment with 6-15 mg of AT IgG (Table III)  was effective in 
slightly  reducing  the morphologic  and  functional  characteristics  of  typical 
allogra/t  destruction  in  the  day  7 animal,  and  the  animals  so  treated  had 
ERPF  values  of  about  one-third  normal,  while  the  animals  injected  with 
16  mg of normal  rabbit  IgG had  nonfunctioning  kidneys.  In  the  group  of 
animals  treated with 25 mg of anti-LBN  Fx  thymus  IgG (lot No. 5), there 
was also significant  renal function, compared to the group treated with anti- 
sera  incompletely  absorbed  with  Lewis  thymocytes which  had  completely 1116  RENAL  TRANSPLANTATION IN RATS. Ill 
rejected kidneys. This would  indicate that the antibody transferred on the 
donor kidney was  not of histocompatibility antigen specificity,  but of anti- 
lymphocytic or "immunosuppressive" specificity and reactive to lymphocytes 
of both rat strains.  At the time of study, 7 days after allotransplantation, the 
recipients had detectable antibody to the rabbit IgG, further proof of antibody 
transfer on kidney and its subsequent dissociation to immunize the new host. 
On the basis of organ localization  data obtained by the paired label method, 
the amount of IgG transferred in such a donor pretreatment experiment  could 
o--.-o  o,  :  = 
6  "%,  0.6 
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TExT-FIG.  6.  In vitro binding  of anti-thymus IgG to purified rat  glomerular basement 
membranes (GBM), performed with the paired iodine label technique. When a fixed amount 
of iodine-labeled AT IgG and NR IgG was mixed with increasing amounts of GBM, increas- 
ing amounts of AT IgG was bound  (closed circles), amounting to 2% of the AT IgG at the 
highest antigen level. Only 0.3% of the NR IgG remained with the washed GBM at each of 
the antigen concentrations. The open circle plot shows the ratio of bound AT IgG at each 
concentration of GBM and indicates a progressive saturation of binding sites. 
not exceed 15-25 #g of antibody protein, and 80%  of this would be within 
the proximal  tubular  cells. Since 200-300 /~g NR  IgG  given  intravenously 
for the immune elimination studies failed to induce an immune response over 
a  course  of 3 wk,  the renal bound and transferred antibody IgG was  con- 
siderably more immunogenic than normal IgG, probably because its binding 
site directed  it to a  critical  area in the lymphoid system, demonstrating in 
another way the ability of anti-lymphocyte antibody to augment the immune 
response  to itself. 
In  Vitro  Localization  of  Anti-thymocyte  Antibody  on  Glomerular  Basement 
Membrane,--In  an  in vitro  glomerular  basement membrane-binding experi- 
ment using  the paired  label  technique  (Text-fig.  6),  some antibody activity 
was demonstrated towards purified  glomerular  basement membrane  (GBM) GUTTMANN, CARPENTER, LINDQUIST, AND MERRILL  1117 
antigens. 2 % of the AT IgG bound to GBM while only 0.3 % of NR IgG bound 
nonspecifically. 
Development  of  Immune  Complex and  Autologous  Phase-Nephrotoxic 
Nephritis.--The crude unabsorbed anti-thymus serum which contained anti- 
body to  serum proteins  caused  severe  immediate glomerular  lesions  in  the 
recipients  which were dose-related  and only mild focal glomerular  alterations 
in  rats  treated with  the  absorbed  and  purified  AT  IgG  or  fragments. No 
evidence for complex-induced nephritis was noted in the transplanted kidney 
in pretreated recipients,  and it may be that the greatly augmented anti-IgG 
response of the host prevented the formation of soluble complexes which would 
have resulted in nephritis.  However,  the in vivo and in vitro evidence  that 
cross-reacting  antibody with glomerular  basement membrane specificity was 
present in these  preparations made possible the development of nephrotoxic 
nephritis.  In rats given a series of five intravenous injections of the AT IgG or 
the AT F(ab')~, there was no significant immediate proteinuria (greater than 
15  rag/day).  However,  6-7  wk  after  this  series of  injections,  the  animals 
showed an increase  in their protein excretion from 40 mg to as high as  110 
rag/24 hr with gradual clearing over the next 3 wk. Tissue sections of kidney 
examined  by immunofluorescence at this time showed a  linear deposition  of 
host IgG along basement membrane, confirming the presence of an autologous 
phase-nephrotoxic  nephritis  (48). Furthermore, on the basis of the quantita- 
tive data obtained with localization  of this lot of AT IgG using the paired 
label method, it can be estimated that during the standard series of the 5-8 
injections  of 6-10  mg  of AT  IgG,  approximately  1-2  #g  of kidney-fixing 
antibody (glomerular) was delivered to each animal, a dose sufficient to induce 
autologons phase-nephrotoxic nephritis if all were fixed to glomerular basement 
membrane,  and if an  adequate host response  to  the foreign  protein occurs 
(48). The abundant antibody response  in these  anti-thymocyte-treated ani- 
mals has been shown above. A second series of animals, followed for 3 months 
after intravenous injection of a different lot of AT IgG, developed only border- 
ine and transient increases in protein excretion to 15 mg/day at 6-8 wk. 
DISCUSSION 
The characteristics  of the heterologous rabbit antisera reported here in terms 
of titer against lymphocytes and lymphopenic effects (in vivo)  are in agree- 
ment with the work of others (4,  8, 49-54).  F(ab')2  and F(ab')  pepsin  frag- 
ments of AT IgG are capable  of suppressing the allograft response to kidney 
allotransplants in rats to a degree nearly as effective as administration of the 
IgG (7S) fraction, while normal rabbit serum  or its fractions,  as well as an 
antigiomerular antibody, has no immunosuppressive  effect. Further evidence 
of the potency of our AT IgG preparation was obtained when a 10 mg pretreat- 
ment dose prolonged survival in a group of three rats allowed to live beyond 1118  RENAL  TRANSPLANTATION  IN  RATS.  III 
the 7 day study period. They are alive at present with normal urea nitrogen 
and ERPF 28 days posttransplant. 
Several lines of evidence have been presented to show that the sera raised 
against thymocytes contain antibodies of different specificities  or cross-reac- 
tivities. Basement membrane specificity has been demonstrated by in vivo and 
in vitro experiments which show that an antibody against glomerular basement 
membrane is present which most likely arises from the presence of stromal 
contamination in the immunizing preparation. A side effect of the use of anti- 
thymus IgG, related to the presence of anti-basement membrane antibody in 
some lots, was the development of an autologous phase-nephrotoxic nephritis. 
Since a second lot of antisera tested for this potential produced only borderline 
changes in protein excretion, it is apparent that variations among rabbits in 
their  response  to  basement  membrane  antigens  must  exist.  Once  a  small 
amount (less than 2 #g)  of rabbit antibody is fixed to glomeruli, the greatly 
augmented host antibody response to the foreign protein will assure the de- 
velopment  of  proteinuria  with  deposition  of  immunoglobulins and  comple- 
ment along the basement membranes. It is noteworthy that only 10 % of the 
radioactivity in kidneys was in the glomeruli, and the bulk of the remainder 
was within the cytoplasm of proximal tubular cells, an important site of gamma 
globulin catabolism in  the  rat  (55).  Therefore,  such localization could be  a 
result of reabsorpfion of filtered normal IgG, or could represent  catabolism 
of IgG denatured prior to injection, or could be a  result of immune interac- 
tion  elsewhere  in  the  body.  Either  possibility would  explain  the  increased 
tubular localization of AT IgG as compared to NR IgG, since localization of 
the former in  giomeruli could produce  an increased permeability to  plasma 
proteins. Antibodies to various serum proteins were noted in some batches of 
antisera and, if not removed, induced a  glomerular lesion characteristic of im- 
mune complex deposit disease.  Thus,  it is apparent  that these heterologous 
antisera are potentially nephritogenic by two different mechanisms: formation 
of soluble antigen-antibody complexes,  or  the  presence  of  anti-kidney anti- 
bodies (56). 
Another specificity of the ATS revealed by the mast cell assay for histamine 
release in vitro is best explained by the fact that the thymus contains mast 
cells which were probably present in the immunizing suspensions. It has been 
noted  that  intravenous administration  of ATS  in  high  dosages  produces  a 
toxic reaction (10,  11) which could be related to a  pharmacologic mechanism 
such as histamine release, although the presence of endotoxin in the  various 
preparations  has not been  excluded. 
Many of  the  rabbit  antisera  and  fractions contained  anti-sheep  red  cell 
agglutinating  activity  and  some of  them were  entirely mercaptan-resistant 
(7S).  Since it has been reported that ALS will depress the immune response 
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not the preparations used contained anti-sheep red cell antibody, the results 
cited cannot be attributed solely to a specific effect of ALS but could have been 
due in part to the passive  transfer of antibody to sheep RBC's (59). This is 
supported by our finding that pretreatment with 10 mg of the globulin frac- 
tion of ATS with a titer of 1:8 (all 7S) to sheep erythrocytes suppressed  ag- 
glutinin formation when  tested 6  days after an intravenous challenge  with 
sheep cells. Absorption,  however, of the anti-thymus globulin with sheep cells 
prior to administration of the same dose did not suppress  agglutinin formation. 
Although it is not clear whether the anti-sheep erythrocyte titers found in the 
anti-thymocyte preparations are a  reflection  of a  cross-reacting  antibody to 
rat thymocytes, absorption  of the AT globulin with sheep  red cells did not 
significantly alter the titer to rat thymocytes. The failure to suppress antibody 
formation to  sheep  cells with antibody fragments of ALS in another study 
(58) may have been due to the species involved or the low dosages employed 
but absence of anti-sheep  red cell antibody may have played a role. 
It  has  been  stated  that  the  immunosuppressive  properties  of ALS  may 
prevent an immune response to itself (7) based on the evidence of Monaco et 
al. (5) that mice treated with ALS failed to make such a response to the foreign 
protein.  The data of the present study fail to support this finding since aug- 
mented responses  to the foreign  protein were  the rule.  One  reason  for this 
discrepancy may be that our studies were done with a lower dosage of anti- 
body. Monaco et al. injected their mice with several plasma volumes of ALS 
over a 3 wk period and then looked for antibody to rabbit IgG 1 wk after the 
last injection.  The failure  to detect an antibody response may have been due 
to not having allowed  sufficient  time for the  clearance  and metabolism of 
the  foreign  protein,  which may  cause  immunological  paralysis  or  prevent 
detection of free antibody in the circulation.  On the other hand, the immune 
response may have been  truly altered because of a massive lymphocytotoxic 
effect, or because of the use of whole serum which may produce  some degree 
of antigen competition to IgG (60). However,  administration of several pro- 
teins in the form of anti-lymphocyte globulin to a large series of human pa- 
tients  did  not  suppress  the  development of  anti-horse  precipitins  (11). It 
seems reasonable to explain the higher antibody titers to IgG in the AT IgG-- 
treated rats compared to normal IgG--treated  controls by assuming that more 
antigen, i.e. rabbit IgG, is delivered  to the immune system by virtue of its 
anti-lymphocyte specificity.  Supporting  evidence  for  this  concept  is  found 
in the isotope localization  data which show that more specific antibody fixes 
in lymphoid tissue than NR IgG. Such localization in lymphoid tissue and in 
kidney by anti-rat lymph node antibody has been previously observed  (61). 
The higher titers in the experimental  animals probably do not reflect a type of 
enhancement of antibody formation similar to the effect of X-ray or cytotoxic 
drugs (62, 63)  but alternatively could be due to an adjuvant effect of circu- 1120  RENAL  TRANSPLANTATION  IN  RATS.  III 
lating particulate material  (destroyed  lymphocytes) (64), or  in the case  of 
the antibody fragments, be due to cell-bound antigen delivery producing  an 
adjuvant effect. The mechanism of the observation  of Frenkel et al. (57) that 
AL IgG-treated rats make more antibody than NR IgG--treated controls when 
subsequently immunized  with keyhole limpet hemocyanin may also  be  ex- 
plained by an adjuvant hypothesis. 
The exact mechanisms of action of ALS in suppressing the immune response 
to tissue allografts remain obscure although several important factors emerge. 
It has been stressed by Monaco et al.  ($)  that the lymphocytotoxic effect as 
evidenced by lymphopenia and cell depletion in lymphoid organs in chronically 
treated animals may be responsible for the immunosuppressive  ability of the 
antisera.  Waksman et  al.  (50) previously  demonstrated,  as  well,  that  the 
lymphopenia induced by ALS correlated  with the absence of the cellular re- 
sponse  in  delayed  hypersensitivity, and  Turk  and  Willoughby  (65) have 
pointed out that both central and peripheral  effects of the antisera on cellular 
inflammatory reactions  may be operative.  Although it is true that sustained 
lymphopenia and depletion  of cells from lymphoid organs can occur with the 
administration of massive amounts of ALS, this is not a necessary  condition 
for immunosuppression  to renal allografts,  since pretreatment with AT IgG 
will  effectively cause significant prolongation  of  graft survival  even  though 
lymphopenia may be only transient. Furthermore, the fact that AT (Fab')~ and 
AT Fab  / fragments produced prolongation  of renal allograft survival is evi- 
dence  against  lymphocytotoxicity as  the  necessary  condition for  immuno- 
suppression.  The plasma clearance  rates of the F(ab')~  and Fab' are similar 
to the values obtained for gamma globulin fragments of heterologous proteins 
in various other species combinations  (66). The rapid renal clearance of these 
fragments probably accounts for the finding that increased dosage is required 
to demonstrate an immunosuppressive  effect when the intravenous route is 
used, since not all of the specific antibodies would have a chance to fix in vivo 
prior to their presentation to the kidney. Although the Fab  ~ is less effective 
than the IgG on a dose basis, it would lend itself well to a study of its effect 
on cells and membranes  in vitro since agglutination or cytotoxicity need not 
complicate the system. Levey and Medawar (7) have postulated that "sterile 
activation" of lymphocytes may be  the  immunosuppressive  mode of action 
of ALS. They have noted many blast forms in the peripheral  blood and tissues 
of treated animals. Moreover,  it has been shown that ALS in mixed leukocyte 
culture  is  very  effective  in  inducing blast  transformation  (67). Reasoning 
from the data we have obtained in our system, it would seem that observations 
of increased  blastogenesis in vivo and in vitro can be explained  on the basis 
of the marked immunogenicity of the AT IgG, and its effectiveness in this 
regard is due to the delivery  of the AT antibody as  an antigen to  the ceil 
membrane where the transformation is induced. Thus the possibility of a form 
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in the immunosuppressive ability of ALS is suggested by our studies. For the 
reasons presented above, the binding site and affinity of the antibody molecule 
for lymphoid cells renders it a much more efficient competitor than circulating 
antigen which would rely on a more random type of interaction with the im- 
mune system. 
The present data also show that the antibodies which fix to kidney and dis- 
sociate with a half-life of 0.8-2.6 days are biologically  effective as immunosup- 
pressive antibodies since  donor pretreatment  produces some prolongation  of 
kidney  survival  after  transplantation  in  to  an  unmodified  recipient.  The 
significant  amount of renal binding is in part due to the route of administra- 
tion  of the AT IgG,  since  subcutaneous administration  produces very little 
kidney localization.  Since antibody specifically made against isolated glomeruli 
was not immunosuppressive, target organ specificity per se cannot be a critical 
requirement. Absorption experiments showed that the kidney-bound antibody 
was of anti-lymphocyte specificity and not directed against histocompatibility 
antigens; therefore a degree of true cross-reactivity probably exists,  and  these 
experiments  are not  an  example of enhancement  in  the usual context  (68). 
However, it cannot be ascertained for certain,  given the dissociation  kinetics 
of this antibody, whether there may be a local immunosuppressive effect by a 
masking  of  histocompatibility  antigens  thereby  preventing  the  release  of 
antigen  or by interfering  with  lymphocyte  sensitization  or function  in  the 
destruction of the allograft.  Furthermore, the fact that the recipients of donor 
pretreated kidneys had abundant antibody to the foreign protein, although a 
subimmunogenic dose in terms of NR IgG was transferred, indicates that the 
dissociating AT antibody is a potent immunogen,  and therefore probably has 
some lymphoid cell membrane specificity as a part of its binding site. 
SUMMARY 
Heterologous rabbit  anti-rat  thymocyte sera,  its imruunoglobulin  G  frac- 
tion,  and the bivalent and univalent  antibody fragments obtained by pepsin 
digestion are potent immunosuppressive reagents when tested in a  system of 
renal allotransplantation  between the LBN F1 hybrid and Lewis rat strains. 
The AT F(ab'), is not lymphocytotoxic in vitro but has agglutinating ability, 
while  the AT Fab' neither  agglutinates nor is cytotoxic to rat lymphocytes, 
but will inhibit the in vitro reaction.  The AT IgG and the F(ab')9 are more 
immunogenic in their host than normal rabbit IgG and F(ab')2, probably due 
to increased delivery of the antibody to the immune system. 
Donor  pretreatment  studies  demonstrate  that  a  cross-reacting,  highly 
immunogenic  antibody with  anti-lymphocyte  specificity may bind  to  renal 
sites and be transferred  to the  new  host  after  transplantation.  In addition, 
the crude unabsorbed anti-thymocyte antisera  may induce a  nephritis  char- 
acteristic of immune  complex  disease  which can be eliminated by complete 
absorption with serum proteins.  Further in vivo and in vitro evidence is pre- 1122  RENAL  TRANSPLANTATION  IN  RATS.  ]~I 
sented  that  the  AT IgG contains  small  amounts  of antibody  to  glomerular 
basement membrane antigens  and  may induce  an  autologous  phase-nephro- 
toxic nephritis. The amount of in vivo binding by AT IgG to GBM was reduced 
by subcutaneous  rather  than  intravenous  administration. 
Most of the  rabbit antisera  tested  contain  antibody in  low  titer  to  sheep 
erythrocytes and in vivo experiments indicate that the nature of the immuno- 
depressive effect of AT globulin  to sheep erythrocytes is due in part  to  the 
passive  transfer  of  antibody  and  is  not  necessarily  due  to  a  specific  anti- 
lymphocyte effect. 
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Fro. 1.  Control 7 day renal allograft. Recipient was pretreated with normal rabbit 
IgG. The graft shows morphologic evidence of complete rejection. Hematoxylin and 
eosin. ×  125. 
FIG. 2.  7 day renal allograft from a recipient that was pretreated with rabbit anti- 
rat thymocyte IgG. The only morphologic evidence of aUograft rejection consists of a 
small perivascular  collection of mononuclear  cells (upper  right).  Hematoxylin and 
eosin.  X  125. 
Fro.  3.  Normal rat  thymus. The wide  cortex  contains  medium  and  large  sized 
thymocytes. Many of  the  treated  rats  had  thymuses  indistinguishable  from  this. 
Hematoxylin and eosin. X 45. 
FIG. 4. Thymus from rat treated  with  10 mg rabbit anti-rat thymocyte IgG. The 
cortex is thinned  and depleted  of small, medium,  and large-sized thymocytes.  The 
medulla of the thymus also shows depletion of thymocytes.  Hematoxylin  and eosin. 
X 45. 
Fro.  5.  l~dioautograph of kidney  from  normal  rat receiving 125I normal  rabbit 
IgG and killed 4 days later. Hematoxylin  and eosin. X 250. 
FIG. 6.  Radioautograph  of kidney  from normal  rat receiving 1~I anti-thymocyte 
IgG and killed 4 days later. Hematoxylin and eosin. X 250. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 126  PLATE  86 
(Guttmann et al.: Renal transplantation in rats) 